These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 14531043

  • 21. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
    Otsuka M, Ichiya Y, Hosokawa S, Kuwabara Y, Tahara T, Fukumura T, Kato M, Masuda K, Goto I.
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
    [Abstract] [Full Text] [Related]

  • 22. Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
    Tackenberg B, Metz A, Unger M, Schimke N, Passow S, Hoeffken H, Hoffmann GF, Müller U, Nolte D, Oertel WH, Eggert K, Möller JC.
    Mov Disord; 2007 Apr 30; 22(6):900-2. PubMed ID: 17377924
    [No Abstract] [Full Text] [Related]

  • 23. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty.
    Felicio AC, Shih MC, Godeiro-Junior C, Andrade LA, Bressan RA, Ferraz HB.
    Neurologist; 2009 Jan 30; 15(1):6-16. PubMed ID: 19131852
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Anterograde Degeneration of the Nigrostriatal Pathway Visualized by 123I-FP-CIT SPECT in a Patient With Artery of Percheron Infarction.
    Nakadate M, Miyamoto N, Starkey J, Toriihara A, Tateishi U.
    Clin Nucl Med; 2016 Jun 30; 41(6):483-4. PubMed ID: 26914571
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Role of dopamine transporter SPECT for the practitioner and the general neurologist.
    Oertel WH, Gerstner A, Höffken H, Dodel RC, Eggert KM, Möller JC.
    Mov Disord; 2003 Oct 30; 18 Suppl 7():S9-15. PubMed ID: 14531040
    [Abstract] [Full Text] [Related]

  • 28. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
    Løkkegaard A, Werdelin LM, Friberg L.
    Eur J Nucl Med Mol Imaging; 2002 Dec 30; 29(12):1623-9. PubMed ID: 12458397
    [Abstract] [Full Text] [Related]

  • 29. Molecular imaging of dopamine transporters.
    Brooks DJ.
    Ageing Res Rev; 2016 Sep 30; 30():114-21. PubMed ID: 26802555
    [Abstract] [Full Text] [Related]

  • 30. PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
    Piccini P, Turjanski N, Brooks DJ.
    J Neural Transm Suppl; 1995 Sep 30; 45():123-31. PubMed ID: 8748617
    [Abstract] [Full Text] [Related]

  • 31. Role of DAT-SPECT in the diagnostic work up of parkinsonism.
    Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, Oertel W, Tolosa E, Lees AJ, Poewe W.
    Mov Disord; 2007 Jul 15; 22(9):1229-38. PubMed ID: 17486648
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K, Casteels C, De Ceuninck L, Vanbilloen B, Maes A, Mortelmans L, Vandenberghe W, Verbruggen A, Dom R.
    J Nucl Med; 2006 Mar 15; 47(3):384-92. PubMed ID: 16513606
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Diagnosis of drug-induced parkinsonism: can transcranial sonography make the difference?
    Poewe W, Seppi K.
    Eur J Neurol; 2013 Nov 15; 20(11):1429-30. PubMed ID: 23678988
    [No Abstract] [Full Text] [Related]

  • 37. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
    Kim Y, Kim JM, Kim JW, Yoo CI, Lee CR, Lee JH, Kim HK, Yang SO, Chung HK, Lee DS, Jeon B.
    Mov Disord; 2002 May 15; 17(3):568-75. PubMed ID: 12112209
    [Abstract] [Full Text] [Related]

  • 38. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS, Jeong JM, Park SS, Kim JM, Chang YS, Song HC, Kim KM, Yoon KY, Lee MC, Lee SB.
    Ann Neurol; 1998 Jun 15; 43(6):792-800. PubMed ID: 9629849
    [Abstract] [Full Text] [Related]

  • 39. [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
    Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brücke T.
    Mov Disord; 2002 May 15; 17(3):518-23. PubMed ID: 12112200
    [Abstract] [Full Text] [Related]

  • 40. Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans.
    Lang AE, Garnett ES.
    Ann Neurol; 1990 Oct 15; 28(4):592-3. PubMed ID: 2252376
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.